Citius Oncology, Inc. Stock Issued During Period, Shares, Issued for Services
Citius Oncology, Inc. (CTOR) had Stock Issued During Period, Shares, Issued for Services of 6.65 million shares as of 2024-01-17, per its 10-Q filed 2024-08-09.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesIssuedForServices · last filed 2024-08-09
- 2024-01-17: Stock Issued During Period, Shares, Issued for Services 6.65M shares.
| Period end | Stock Issued During Period, Shares, Issued for Services |
|---|---|
| 2024-01-17 | 6.65M shares 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |